Companies face different situations today when moving into a strategic approach to IP management. This white paper aims to summarize these situations and reflects the views of ~400 IP and innovation professionals working in IP and innovation (R&D, R&I or the like) departments in a wide range of companies (large and SMEs), patent law firms and other organizations. The document is a compilation of both positive and less positive experiences, i.a. on the design, the implementation and the execution of the IP plan.
Download now the white paper 'IP strategy'.
Editor: Patentopolis B.V.
Combined offer of three compulsory seminars plus one elective module for (future) Heads of the Pharmacovigilance Department - learn the responsibilities and legal aspects of managing a PV system and its staff, and select an elective module according to your individual interests.
Combination of three selected seminars - with this qualification course, you will first gain insight into the legal aspects and general responsibilities of the Qualified Person for Pharmacovigilance (QPPV). You will then deepen your professional and practical knowledge to perform your role more effectively.
This e-Learning programme will provide you with knowledge on Good Distribution Practice in today's pharmaceutical industry
Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.
Our e-learning, specially tailored for medical device advisors, provides you with the essential knowledge to navigate your professional duties confidently and in full legal compliance.
This e-learning programme will familiarise you with the regulatory affairs principles involved in applying for a marketing authorisation in Europe (MRP, DCP, CP) . It will also introduce you to post-authorisation duties (renewal, variation...).
Are you a specialist in the pharmaceutical industry in the area of marketing authorisation and responsible for compiling the quality documentation of active pharmaceutical ingredients (APIs) and their starting material? Then this is the right seminar for you! Including an update on the new ICH Q1, M4Q(R2) and ASMF matters, as well as new regulatory trends including ICH Q12, reliance and AI.
During our online training "Toxicology and beyond: Safety assessment in drug development" you will build a solid toxicological know-how basis and will be informed about the inclusion of toxicological data in the marketing authorisation dossier. Take the chance and participate in our interactive online training.
This online event offers a comprehensive overview of marketing authorisation and market access in the Middle East, covering key topics like market entry, intellectual property, lifecycle management, pharmacovigilance and quality considerations, with a focus on Gulf Cooperation Council, Saudi Arabia, the UAE, Jordan and Syria.
Non-clinical/clinical content in the dossier: Are you a beginner in the field and would like to feel confident working competently on modules 2, 4 and 5 in the future? Are you already an experienced specialist and would like to refresh, professionalise or "structure" your knowledge? Then you've come to the right place!
You will gain actionable insights into global market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.
